Reduce the use of beta cell CD20 CD37 - and promise special points

摘要

The method provided by the present invention reduces the general B cell commitment on a person using a specific molecule CD37. Specifically, the present invention provides a method to reduce the use of CD37 by B cell specific molecules to promise only specific molecules or a combination of CD37 commitments. Specific commitment and CD20 molecule, in some cases, a synergist combination.The invention also provides materials and methods for treating diseases, including abnormal B cell activity. In addition, the invention provides a promise of alpha, theta, PGE, CD37, and especially the promise of molecules.